親子鑑定·血緣鑑別檢驗服務的全球市場:各用途，各產品預測 - 附執行和顧問指南(2023年～2027年)

本報告提供全球親子鑑定·血緣鑑別檢驗服務市場相關調查，提供市場概要，以及各用途，各產品趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 市場指南

第2章 簡介和市場定義

第3章 市場概要

• 市場進入組織
  • 學術研究機關
  • 診斷測試開發商
  • 儀器供應商
  • 藥品·試劑廠商
  • 病理供應商
  • 獨立型臨床檢驗室
  • 公共的國立/地區研究所
  • 醫院檢驗室
  • 臨床檢驗室
  • 審核機關
  • 認證機關
• 血緣鑑別檢驗

第4章 市場趨勢

• 測量，自動化，診斷趨勢
• 成長促進因素
• 阻礙成長的要素

第5章 血緣鑑別檢驗的最近發展

第6章 主要企業簡介

• AlphaBiolabs
• Bureau Veritas
• Canadian DNA Services
• Easy DNA
• Eurofins Scientific
• Gene by Gene, Ltd.
• Genex Diagnostics
• Intelligenetics
• Invitae Corporation
• Laboratory Corporation of America
• Myriad Genetics/Myriad RBM
• Quest Diagnostics
• Verogen

第7章 世界市場規模

• 各國全球市場
• 各用途的全球市場
• 各產品的全球市場

第8章 全球血緣鑑別檢驗市場規模，各用途

• 法規
• 移民檢驗
• 臨床
• 消費者的自由裁量權

第9章 全球血緣鑑別檢驗市場，各產品

• 設備
• 試劑·套件
• 軟體
• 服務

OVERVIEW:

Its not just paternity testing anymore! Maternity testing, Grandparent testing. Sibling testing. Infidelity testing? Who knew? It's all up for grabs in this new growth industry. Direct to Consumer genetic testing is driving the need for legally recognized relationship testing. Suppliers can benefit from non mainstream demand as well. DNA testing is crossing the chasm and moving into everyday life.

Like any service the key is reaching the customer when they are in need. Find out all about the opportunities and pitfalls in this developing industry.

This is a complex area, but this readable report will bring the entire management team up to speed, on both the technology and the opportunity. The technology is moving fast. It is coming out of the lab and onto the desktop as genetics crosses the chasm into mainstream commerce.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

• B.Sc. (Chemistry) University of BC
• M.B.A. (Finance and Policy) University of BC
• Market Research Seminar - Burke Institute
• Finance for Senior Executives - Harvard Business School

Table of Contents

1 Market Guides

• 1.1 Relationship Testing - Strategic Situation Analysis
• 1.2 Guide for Executives, Marketing, Sales and Business Development Staff
• 1.3 Guide for Management Consultants and Investment Advisors

2 Introduction and Market Definition

• 2.1 What is Paternity & Relationship Testing?
• 2.2 The Genomics Revolution
• 2.3 Market Definition
  • 2.3.1 Revenue Market Size.
  • 2.3.2 Legal
  • 2.3.3 Migrant
  • 2.3.4 Clinical
  • 2.3.5 Discretionary
  • 2.3.6 Instruments
  • 2.3.7 Reagents
  • 2.3.8 Software and Services
• 2.4 Methodology
  • 2.4.1 Methodology
  • 2.4.2 Sources
  • 2.4.3 Authors
• 2.5 Perspective: Healthcare and the IVD Industry
  • 2.5.1 Global Healthcare Spending
  • 2.5.2 Spending on Diagnostics
  • 2.5.3 Important Role of Insurance for Diagnostics
• 2.6 Chromosomes, Genes and Epigenetics
  • 2.6.1 Chromosomes
  • 2.6.2 Genes
  • 2.6.3 Epigenetics

3 Market Overview

• 3.1 Players in a Dynamic Market
  • 3.1.1 Academic Research Lab
  • 3.1.2 Diagnostic Test Developer
  • 3.1.3 Instrumentation Supplier
  • 3.1.4 Chemical/Reagent Supplier
  • 3.1.5 Pathology Supplier
  • 3.1.6 Independent Clinical Laboratory
  • 3.1.7 Public National/regional Laboratory
  • 3.1.8 Hospital Laboratory
  • 3.1.9 Physicians Office Lab (POLS)
  • 3.1.10 Audit Body
  • 3.1.11 Certification Body
• 3.2 Relationship Testing
  • 3.2.1 Overview
  • 3.2.2 Legal Use - a special case
    • 3.2.2.1 Legal
    • 3.2.2.2 Private
  • 3.2.3 Rights and Responsibilities - a complex picture
  • 3.2.4 Forensic Usage
  • 3.2.5 Clinical Uses
  • 3.2.6 Familial and Discretionary Use
  • 3.2.7 Role of Direct to Consumer Genetic Testing Services
  • 3.2.8 Immigration Use

4 Market Trends

• 4.1 Instrumentation, Automation & Diagnostic Trends
  • 4.1.1 Traditional Automation and Centralization
  • 4.1.2 The New Automation, Decentralization and Point Of Care
  • 4.1.3 Instruments Key to Market Share
  • 4.1.4 Bioinformatics Plays a Role
  • 4.1.5 PCR Takes Command
  • 4.1.6 Next Generation Sequencing Fuels a Revolution
  • 4.1.7 NGS Impact on Pricing
  • 4.1.8 Whole Genome Sequencing, A Brave New World
  • 4.1.9 Companion Diagnostics Blurs Diagnosis and Treatment
• 4.2 Factors Driving Growth
  • 4.2.1 Genetics Takes Center Stage
  • 4.2.2 Cultural Shifts - Changing Meaning of Family
  • 4.2.3 Media & Celebrity
  • 4.2.4 Ancestry - Changing Attitudes
• 4.3 Factors Limiting Growth
  • 4.3.1 Increased Competition Lowers Price
  • 4.3.2 Lower Costs
  • 4.3.3 Values Shifting
  • 4.3.4 DTC Competition

5 Relationship Testing Recent Developments

• 5.1.1 Importance of This Section
• 5.1.2 How to Use This Section
• 5.2 Maury Povich Launches At-Home Paternity Test
• 5.3 Paternity Test Unveils IVF Mistake
• 5.4 Anti-Trafficking Agency Conducts Paternity Tests
• 5.5 Supreme Court limits DNA paternity testing
• 5.6 New law proposes DNA testing to weed-out false declarations of paternity
• 5.7 AffinityDNA Acquisition expands direct-to-consumer business
• 5.8 EasyDNA expands markets
• 5.9 AlphaBiolabs accredited as demand for prenatal paternity testing soars
• 5.10 Genetic Technologies to Acquire DTC Genetic Test Provider EasyDNA
• 5.11 DNA Diagnostics Center to Join Eurofins via Acquisition
• 5.12 Bode and Gene By Gene Receive Approval
• 5.13 Pioneers, myDNA and FamilyTreeDNA Merge
• 5.14 Researchers Urged to Adopt New Genomic Technologies for Relationship Testing
• 5.15 'Not the Father': Baltimore Man Filing suit
• 5.16 Thermo Fisher Scientific Applied Biosystems SeqStudio Genetic Analyzer for Human
• Identification

6 Profiles of Key Companies

• 6.1 AlphaBiolabs
• 6.2 Bureau Veritas
• 6.3 Canadian DNA Services
• 6.4 Easy DNA
• 6.5 Eurofins Scientific
• 6.6 Gene by Gene, Ltd.
• 6.7 Genex Diagnostics
• 6.8 Intelligenetics
• 6.9 Invitae Corporation
• 6.10 Laboratory Corporation of America
• 6.11 Myriad Genetics/Myriad RBM
• 6.12 Quest Diagnostics
• 6.13 Verogen

7 Global Relationship Testing Market Size

• 7.1 Global Market by Country
  • 7.1.1 Table - Global Market by Country
  • 7.1.2 Chart - Country Market Shares
• 7.2 Global Market by Application
  • 7.2.1 Table - Global Market by Application
  • 7.2.2 Chart - Application Share by Year
  • 7.2.3 Chart - Application Segment Growth Rates
  • 7.2.4 Chart - Application Segment Share Shifts
  • 7.2.5 Chart - Application Segment Share Base Year
  • 7.2.6 Chart - Application Segment Share Final Year
• 7.3 Global Market by Product
  • 7.3.1 Table - Global Market by Product
  • 7.3.2 Chart - Product Share by Year
  • 7.3.3 Chart - Product Segment Growth Rates
  • 7.3.4 Chart - Product Segment Share Shifts
  • 7.3.5 Chart - Product Segment Share Base Year
  • 7.3.6 Chart - Product Segment Share Final Year

8 Global Relationship Market Sizes by Application

• 8.1 Legal Market
  • 8.1.1 Table Legal - by Country
  • 8.1.2 Chart - Legal Growth
• 8.2 Migrant Testing Market
  • 8.2.1 Table Migrant - by Country
  • 8.2.2 Chart - Migrant Growth
• 8.3 Clinical Market
  • 8.3.1 Table Clinical - by Country
  • 8.3.2 Chart - Clinical Growth
• 8.4 Consumer Discretionary Market
  • 8.4.1 Table Consumer Discretionary - by Country
  • 8.4.2 Chart - Consumer Discretionary Growth

9 Global Relationship Testing Market by Product

• 9.1 Instruments Market
  • 9.1.1 Table Instruments - by Country
  • 9.1.2 Chart - Instrument Growth
• 9.2 Reagents and Kits Market
  • 9.2.1 Table Reagents and Kits - by Country
  • 9.2.2 Chart - Reagents and Kits Growth
• 9.3 Software Market
  • 9.3.1 Table Software - by Country
  • 9.3.2 Software Growth
• 9.4 Services Market
  • 9.4.1 Table Services - by Country
  • 9.4.2 Chart - Services Growth

Table of Tables

• Table 1 The Base Pairs
• Table 2 Market Players by Type
• Table 3 The Different Types of Relationship Tests
• Table 4 Seven Key Diagnostic Laboratory Technology Trends
• Table 5 Factors Driving Growth
• Table 6 Four Factors Limiting Growth
• Table 7 Global Market by Country
• Table 8 Global Market by Application
• Table 9 Global Market by Product
• Table 10 Legal Segment by Country
• Table 11 Migrant Segment by Country
• Table 12 Clinical Segment by Country
• Table 13 Consumer Discretionary Segment by Country
• Table 14 Instruments Segment by Country
• Table 15 Reagents and Kits Segment by Country
• Table 16 Software Segment by Country
• Table 17 Services Segment by Country

Table of Figures

• Figure 1 Global Healthcare Spending
• Figure 2 The Lab Test Pie
• Figure 3 DNA Strands and Chromosomes
• Figure 4 Karyogram of Human Chromosomes
• Figure 5 Size of Various Genomes
• Figure 6 The Road to Diagnostics
• Figure 7 Centralized vs. Decentralized Laboratory Service
• Figure 8 A Highly Multiplexed Syndromic Testing Unit
• Figure 9 The Real Cost to Sequence the Human Genome
• Figure 10 The Codevelopment Process
• Figure 11 Country Market Shares
• Figure 12 Application Share by Year
• Figure 13 Application Segment Growth Rates
• Figure 14 Segment Share Shifts
• Figure 15 Application Segment Share Base Year
• Figure 16 Application Segment Share Final Year
• Figure 17 Product Share by Year
• Figure 18 Product Segment Growth Rates
• Figure 19 Product Segment Share Shifts
• Figure 20 Product Segment Share Base Year
• Figure 21 Product Segment Share Final Year
• Figure 22 Legal vs. Total Market Growth
• Figure 23 Migrant vs. Total Market Growth
• Figure 24 Clinical vs. Total Market Growth
• Figure 25 Consumer Discretionary vs. Total Market Growth
• Figure 26 Instrument vs. Total Market Growth
• Figure 27 Reagents and Kits vs. Total Market Growth
• Figure 28 Software vs. Total Market Growth
• Figure 29 Services vs. Total Market Growth